ImmunoGen Stock Quote
$3.40 -$0.08 -2.4%
BATS BZX Real Time Price as of November 20, 2019, 4:00 p.m. EST View Interactive IMGN Charts

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs.

News & Analysis: ImmunoGen

The Fool has written over 200 articles on ImmunoGen.


Market Moves


Why ImmunoGen Shares Are Crashing Today

Disappointing news from the FDA means that the biotech company is further from potentially winning approval for its lead drug candidate.

Why ImmunoGen Jumped Today

Anticipation of a big presentation later this week appeared to generate excitement about this clinical-stage biotech.

Interactive Chart